nitric oxide (EDX110) / Edixomed - LARVOL DELTA

A Multi-Centre, Observer-Blinded, Randomized Controlled Trial of EDX110 for the Treatment of Diabetic Foot Ulcers (clinicaltrials.gov) - P=N/A | N=298 | Not yet recruiting | Sponsor: ConvaTec Inc.

New trial

Cost-effectiveness of a nitric oxide-generating medical device in managing hard-to-heal diabetic foot ulcers. (PubMed, J Wound Care) - "However, the location where the dressing is administered (i.e., the community or secondary care) can potentially influence EDX110's cost-effectiveness. Within the limitations of the study, EDX110 could potentially afford the UK's health services a cost-effective treatment for DFUs; however, this is dependent on the location of the healthcare professionals administering the dressing."

HEOR • Journal • Diabetes • Metabolic Disorders

EDX110 - Efficacy and Safety in the Management of Hard-to-heal Wounds (clinicaltrials.gov) - P=N/A | N=80 | Not yet recruiting | Sponsor: ConvaTec Inc.

New trial • Cardiovascular • Diabetes • Metabolic Disorders • Venous Ulcer

IDEAS Conference 2020 - KidneyX Redesign Dialysis Session 1 Part 3 (YouTube) - "Nitric Oxide-Eluting, Disposable Hemodialysis Catheter Cap to Prevent Infection and Thrombosis."

Video